NCT01591616View on ClinicalTrials.gov

Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Periodontal Disease
Interventions
DRUG

lidocaine and prilocaine

Appropriate dose of Oraqix based on weight will be given before tooth extraction

Trial Locations (1)

23298

Virginia Commonweath School of Dentistry, Richmond

Sponsors
All Listed Sponsors
lead

Dentsply International

INDUSTRY

NCT01591616 - Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel | Biotech Hunter | Biotech Hunter